Literature DB >> 22770736

Correlations between population levels of prescription opioid use and prescription-opioid-related substance use treatment admissions in the USA and Canada since 2001.

B Fischer1, N Nakamura, K Urbanoski, B Rush, J Rehm.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22770736     DOI: 10.1016/j.puhe.2012.04.010

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


× No keyword cloud information.
  6 in total

1.  Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009.

Authors:  Kevin D Shield; Wayne Jones; Jürgen Rehm; Benedikt Fischer
Journal:  Pain Res Manag       Date:  2013 Mar-Apr       Impact factor: 3.037

2.  Opioid agonist therapy during residential treatment of opioid use disorder: Cohort study on access and outcomes.

Authors:  Sheryl Spithoff; Christopher Meaney; Karen Urbanoski; Katy Harrington; Bill Que; Meldon Kahan; Pamela Leece; Vivian Shehadeh; Frank Sullivan
Journal:  Can Fam Physician       Date:  2019-10       Impact factor: 3.275

3.  Prescription opioid use and non-fatal overdose in a cohort of injection drug users.

Authors:  Stephanie Lake; Evan Wood; Jane Buxton; Huiru Dong; Julio Montaner; Thomas Kerr
Journal:  Am J Drug Alcohol Abuse       Date:  2015-02-20       Impact factor: 3.829

4.  Prescription opioid misuse and mental health among young injection drug users.

Authors:  Mary E Mackesy-Amiti; Geri R Donenberg; Lawrence J Ouellet
Journal:  Am J Drug Alcohol Abuse       Date:  2014-08-08       Impact factor: 3.829

5.  Harms of prescription opioid use in the United States.

Authors:  Sameer Imtiaz; Kevin D Shield; Benedikt Fischer; Jürgen Rehm
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-10-27

6.  Trends and changes in prescription opioid analgesic dispensing in Canada 2005-2012: an update with a focus on recent interventions.

Authors:  Benedikt Fischer; Wayne Jones; Jürgen Rehm
Journal:  BMC Health Serv Res       Date:  2014-02-26       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.